CSFLI Cuts Non-Motor OFF-Period Fluctuations in Advanced Parkinson’s
In a prospective, single-centre, real-world study of 40 patients with advanced Parkinson’s disease in Naples, Italy, three months of continuous subcutaneous foslevodopa-foscarbidopa infusion (CSFLI) was associated with significant reductions in motor complications and in non-motor fluctuations occurring during OFF periods. The analysis, led by Rosa De Micco of the Department of Advanced Medical and Surgical … Read more